Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 17  •  01:05PM ET
36.98
Dollar change
+0.45
Percentage change
1.23
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y46.46% Total Holdings56 Perf Week1.15%
SponsorTema ETF Type Tagsequity Return% 3Y- AUM150.81M Perf Month0.93%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter12.71%
Index- Average Maturity Tags- Return% 10Y 52W High37.51 -1.41% Perf Half Y38.48%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.10 84.02% Perf YTD6.51%
Active/Passive Quant Type Tags- Flows% 1M9.80% Volatility1.76% 1.90% Perf Year46.69%
Dividend TTM0.02 (0.05%) ESG Type Tags- Flows% 3M45.70% ATR (14)0.71 Perf 3Y-
Dividend Ex-DateDec 10, 2025 Dividend Type Sector/Theme Flows% YTD24.03% RSI (14)58.14 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.94 Perf 10Y-
Expense0.75% Growth/Value SMA201.30% Flows% 3Y Rel Volume0.66 Prev Close36.53
Inverse/Leveraged Market Cap SMA503.45% Flows% 5Y Avg Volume38.56K Price36.98
IPOAug 16, 2023 Option/ShortNo / Yes SMA20025.06% Trades Volume14,678 Change1.23%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.